Vivos Therapeutics
VVOS
VVOS
18 hedge funds and large institutions have $3.12M invested in Vivos Therapeutics in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
71% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 14
Holders
18
Holding in Top 10
–
Calls
$825K
Puts
–
Top Buyers
| 1 | +$709K | |
| 2 | +$623K | |
| 3 | +$21.4K | |
| 4 |
NFSG
Newbridge Financial Services Group
Boca Raton,
Florida
|
+$16.1K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$4.71K |
Top Sellers
| 1 | -$174K | |
| 2 | -$38.8K | |
| 3 | -$16K | |
| 4 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
-$10.2K |
| 5 |
State Street
Boston,
Massachusetts
|
-$8.77K |